Article
Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone…
medRxiv · 2024 · Zhou, L.; Ni, C.; Liao, R.; Tang, X.; Yi, T.; Ran, M.; Huang, M.; Liao, R.; Zhou, X.; Qin, D.; Wang, L.; Huang, F.; Xie, X.; Wan, Y.; Luo, J.; Wang, Y.; Wu, J.
Key facts
| Title | Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia |
|---|---|
| First author | Zhou, L.; Ni, C.; Liao, R.; Tang, X.; Yi, T.; Ran, M.; Huang, M.; Liao, R.; Zhou, X.; Qin, D.; Wang, L.; Huang, F.; Xie, X.; Wan, Y.; Luo, J.; Wang, Y.; Wu, J. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2023.12.16.571981 |
| Devices mentioned | K041074, K062087, K141468, K832428, K910800, K952252, K960557 |
| Product codes mentioned | GHR, GKZ, JPK, OYE, LXG, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1